Literature DB >> 10337505

Anti-labyrinthine antibodies in a patient with relapsing polychondritis.

W J Issing1, D Selover, P Schulz.   

Abstract

Relapsing polychondritis is a rare inflammatory disease that causes destruction of cartilaginous tissue in various anatomical regions. We report here about a 55-year-old female patient with relapsing polychondritis that involved the right auricle, both audiovestibular organs and both eyes. The patient presented with persisting inflammation of the right auricle, sudden lower-frequency hearing loss, acute moderate vertigo with nausea and mild ocular symptoms. Immunofluorescence assays were used for the detection of antibodies against the cochlea and the vestibular organ and demonstrated the presence of circulating antibodies against the audiovestibular organ. No staining for anti-corneal IgG was detected. Improvement of clinical disease was achieved by treatment with systemic steroids and vasodilator drugs, and long-term medication with low-dose corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337505     DOI: 10.1007/s004050050133

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Cochlear implantation in a bilateral sensorineural hearing loss patient with relapsing polychondritis.

Authors:  Young Joon Seo; Jae Young Choi; Si Hong Kim; Tae-Jung Kim
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

2.  Relapsing polychondritis associated with bilateral stapes footplate fixation: a case report.

Authors:  Yohanna M Takwoingi
Journal:  J Med Case Rep       Date:  2009-09-09

3.  Relapsing polychondritis and otologic findings.

Authors:  Serhan Derin; Abdulkadir Oran; Fatma Demirkuru; Selcuk Ucar
Journal:  North Clin Istanb       Date:  2014-12-08

Review 4.  Audiovestibular Symptoms in Systemic Autoimmune Diseases.

Authors:  Massimo Ralli; Vittorio D'Aguanno; Arianna Di Stadio; Armando De Virgilio; Adelchi Croce; Lucia Longo; Antonio Greco; Marco de Vincentiis
Journal:  J Immunol Res       Date:  2018-08-19       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.